Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 6 | 21 | -110 | 2 | 8 |
| Gross Profit | 6 | 21 | -110 | 2 | 8 |
| Operating Expenses | 18,013 | 21,780 | 22,984 | 24,754 | 20,403 |
| Operating Income | -18,007 | -21,759 | -23,094 | -24,752 | -20,395 |
| Interest Expense | -2 | 2 | -183 | 64 | 65 |
| Other Income | 1,944 | 1,687 | 1,251 | 1,103 | 353 |
| Pre-tax Income | -16,061 | -20,074 | -21,660 | -23,713 | -20,107 |
| Income Tax | N/A | N/A | N/A | -197 | N/A |
| Net Income Continuous | -16,061 | -20,074 | -21,660 | -23,516 | -20,107 |
| Net Income | $-16,061 | $-20,074 | $-21,660 | $-23,516 | $-20,107 |
| EPS Basic Total Ops | -0.32 | -0.40 | -0.47 | -0.48 | -0.42 |
| EPS Basic Continuous Ops | -0.32 | -0.40 | -0.46 | -0.48 | -0.42 |
| EPS Diluted Total Ops | -0.32 | -0.40 | -0.47 | -0.48 | -0.42 |
| EPS Diluted Continuous Ops | -0.32 | -0.40 | -0.46 | -0.48 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.40 | -0.43 | N/A | N/A |
| EBITDA(a) | $-18,512 | $-22,115 | $-23,330 | $-24,893 | $-20,342 |